Diagnosis and treatment of geriatric depression

CNS Drugs

Volumn 9, Issue 1, 1998, Pages 17-30

  Lasser, Robert ^a   Siegel, Erika ^b   Dukoff, Ruth ^a   Sunderland, Trey ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b CATHOLIC UNIVERSITY OF AMERICA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; BENZODIAZEPINE DERIVATIVE; DESIPRAMINE; DEXAMPHETAMINE; FLUVOXAMINE; HETEROCYCLIC COMPOUND; METHYLPHENIDATE; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NORFLUOXETINE; NORTRIPTYLINE; PAROXETINE; SELEGILINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

AGING; BEREAVEMENT; DEPRESSION; DOSE RESPONSE; DRUG EFFECT; ELECTROCONVULSIVE THERAPY; GERONTOPSYCHIATRY; HUMAN; MORTALITY; PREVALENCE; PRIORITY JOURNAL; RELAPSE; REVIEW; SUICIDE; TREATMENT OUTCOME;

EID: 0031893257     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-199809010-00003     Document Type: Review

References (136)

1. United Nations Statistical Office. Demographic yearbook. New York: Department of Economic and Social Affairs, United Nations, 1993: 142-53
2. United States, Bureau of the Census. Statistical abstract of the United States. 115th ed. Washington, DC: US Department of Commerce, 1995: 88-9
3. Bland RC, Newman SC, Orn H. Period prevalence of psychiatric disorders in Edmonton. Acta Psychiatr Scand 1988; 77: 43-9
4. Robins LN, Regier DA. Psychiatric disorders in America: the Epidemiological Catchment Area study. New York: The Free Press, MacMillan Inc, 1991
5. Henderson AS, Jorm AF, Mackinnon A, et al. The prevalence of depressive disorders and the distribution of depressive symptoms in later life: a survey using Draft ICD-10 and DSM-III-R. Psychol Med 1993; 23 (3): 719-29
6. Slater SL, Katz IR. Prevalence of depression in the aged: formal calculations versus clinical facts. J Am Geriatr Soc 1995; 43: 78-9
7. Rovner BW, German PS, Brant LJ, et al. Depression and mortality in nursing homes. JAMA 1991 Feb 27; 265 (8): 993-6
8. Parmelee PA, Katz IR, Lawton MP. Incidence of depression long-term care settings. J Gerontol 1992; 47 (6): M189-96
9. Blazer D. The epidemiology of depression in late life. J Geriatr Psychiatry 1989; 22: 35-52
10. Ernst C, Angst J. Depression in old age: is there a real decrease in prevalence? A review. Eur Arch Psychiatry Clin Neurosci 1995; 245: 272-87
11. Knäuper B, Wittchen HU. Diagnosing major depression in the elderly: evidence for response bias in standardized diagnostic interviews? J Psychiatr Res 1994; 28 (2): 147-64
12. Martin LM, Fleming KC, Evans JM. Recognition and management of anxiety and depression in elderly patients. Mayo Clin Proc 1995; 70: 999-1006
13. Richardson JP, Gallo JJ. Geriatrics for the clinician: treatment of depression in the elderly. Md Med J 1996 Jul; 45 (7): 553-6
14. Devanand DP, Nobler MS, Singer T, et al. Is dysthymia a different disorder in the elderly? Am J Psychiatry 1994 Nov; 151 (11): 1592-9
15. Kennedy GJ. The geriatric syndrome of late-life depression. Psychiatr Serv 1995 Jan; 46 (1): 43-8
16. Lebowitz BD, Martinez RA, Niederehe G, et al. Treatment of depression in late life: NIMH/MacArthur Foundation Workshop report. Psychopharmacol Bull 1995; 31 (1): 185-202
17. Tannock C, Katona C. Minor depression in the aged. Drugs Aging 1995; 6 (4): 278-92
18. Blazer D, Hughes DC, George LK. The epidemiology of depression in an elderly community sample. Gerontologist 1987; 27: 281-7
19. Katz IR, Lesher E, Kleban M, et al. Clinical features of depression in the nursing home. Int Psychogeriatr 1989; 1 (1): 5-15
20. Howland RH, Thase ME. Biological studies of dysthymia. Biol Psychiatry 1991 Aug 1; 30 (3): 283-304
21. Hellerstein DJ, Yanowitch P, Rosenthal J, et al. A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia. Am J Psychiatry 1993; 150: 1169-75
22. Wells KB, Burnam MA, Rogers W, et al. The course of depression in adult outpatients: results from the medical outcomes study. Arch Gen Psychiatry 1992 Oct; 49: 788-94
23. Koenig HG, Blazer DG III. Minor depression in late-life. Am J Geriatr Psychiatry 1996; 4 Suppl. 1: S14-21
24. Kivelä SL. Long-term prognosis of major depression in old-age: a comparison with prognosis of dysthymic disorder. Int Psychogeriatr 1995; 7: 69-82
25. Rothschild AJ. The diagnosis and treatment of late-life depression. J Clin Psychiatry 1996; 57 Suppl. 5: 5-11
26. Brodaty H. Think of depression: atypical presentations in the elderly. Aust Fam Physician 1993 Jul; 22 (7): 1195-203
27. Bonner D, Howard R. Treatment-resistant depression in the elderly. Int Psychogeriatr 1995; 7: 83-94
28. Baron M, Mendlewicz, J, Klotz J. Age-of-onset and genetic transmission of affective disorders. Acta Psychiatr Scand 1981; 64: 373-80
29. Fava M, Alpert JE, Borus JS, et al. Patterns of personality disorder comorbidity in early-onset versus late-onset major depression. Am J Psychiatry 1996 Oct; 153 (10): 1308-12
30. Ranga Rama Krishnan K, Gadde KM. The pathophysiologic basis for late-life depression. Am J Geriatr Psychiatry 1996; 4 Suppl. 1: S22-33
31. Folstein SE, Peyser CE, Starkstein SE, et al. Subcortical triad of Huntington's disease: a model for a neuropathology of depression, dementia, and dyskinesia. In: Carroll BJ, Barrett JE, editors. Psychopathology and the brain. New York: Raven Press, 1991: 65-75
32. Coffey CE, Figiel GS. Neuropsychiatric significance of subcortical encephalomalacia. In: Carroll BJ, Barrett JE, editors. Psychopathology and the brain. New York: Raven Press, 1992: 243-64
33. Cummings J. Depression and Parkinson's disease: a review. Am J Psychiatry 1992; 149: 443-54
34. Ranga Rama Krishnan K. Neuroanatomic substrates of depression in the elderly. J Geriatr Psychiatry Neurol 1993 Jan-Mar; 6: 39-58
35. Figiel GS, Rama Ranga Krishnan K, Doraiswamy PM, et al. Subcortical hyperintensities on brain MRI: a comparison between late age onset and early onset elderly depressed subjects. Neurobiol Aging 1991; 26: 245-7
36. Alexopoulos GS, Young RC, Shindledecker R. Brain computed tomography in geriatric depression and primary degenerative dementia. Biol Psychiatry 1992; 31: 591-9
37. Lesser IM, Boone KB, Mehringer CM, et al. Cognition and white matter hyperintensities in older depressed patients. Am J Psychiatry 1996; 153: 1280-7
38. Salloway S, Malloy P, Kohn R, et al. MRI and neuropsychological differences in early-and late-onset geriatric depression. Neurology 1996 Jun; 46: 1567-74
39. Ranga Rama Krishnan K, Turpler LA, Ritchie JC, et al. Apolipoprotein E-e4 frequency in geriatric depression. Biol Psychiatry 1996; 40: 69-71
40. Reding M, Haycox J, Blass J. Depression in patients referred to a dementia clinic: a three-year prospective study. Arch Neurol 1986; 42: 894-6
41. Kral VA, Emery OB. Long-term follow-up of depressed pseudodementia of the aged. Can J Psychiatry 1988 Jun; 34 (5): 445-6
42. Alexopoulos GS, Meyers BS, Young RC, et al. The course of geriatric depression with 'reversible dementia': a controlled study. Am J Psychiatry 1993 Nov; 150 (11): 1693-9
43. Alexopoulos GS, Young RC, Meyers BS. Geriatric depression: age of onset and dementia. Biol Psychiatry 1993; 34: 141-5
44. Boone KB, Lesser I, Miller B, et al. Cognitive functioning in a mildly to moderately depressed geriatric sample: relationship to chronological age. J Neuropsychiatry 1994 Summer; 6 (3): 267-72
45. Wells KB, Stewart A, Hays RD, et al. The functioning and well-being of depressed patients: results from the medical outcomes study. JAMA 1989; 262: 914-9
46. Caine ED, Lyness JM, Conwell Y. Diagnosis of late-life depression. Am J Geriatr Psychiatry 1966; 4 Suppl. 1: S45-50
47. Newhouse P. Use of serotonin selective reuptake inhibitors in geriatric depression. J Clin Psychiatry 1996; 57 Suppl. 5: 12-22
48. Conwell Y. Outcomes of depression. Am J Geriatr Psychiatry 1996; 4 Suppl. 1: S34-44
49. Rovner BW. Depression and increased risk of mortality in the nursing home patient. Am J Med 1993 May 24; 94 Suppl. 5A: 19S-22S
50. Alexopoulos GS, Vrontou C, Kakuma T, et al. Disability in geriatric depression. Am J Psychiatry 1996 Jul; 153 (7): 877-85
51. Brodaty H, Harris L, Peters K, et al. Prognosis of depression in the elderly. Br J Psychiatry 1993; 163: 589-96
52. Alexopoulos GS, Meyers BS, Young RC, et al. Recovery in geriatric depression. Arch Gen Psychiatry 1996 Apr; 53: 305-12
53. Reynolds III CF, Frank E, Kupfer DJ, et al. Treatment outcome in recurrent major depression: a post hoc comparison of elderly ('young old') and midlife patients. Am J Psychiatry 1996; 153: 1288-92
54. Farrell KR, Ganzini L. Misdiagnosing delirium as depression in medically ill elderly patients. Arch Intern Med 1995 Dec 11; 155: 2459-64
55. Kalchthler T, Coccaro E, Lichtiger S. Incidence of polypharmacy in a long-term care facility. J Am Geriatr Soc 1977; 25: 308-13
56. Everitt DE, Avorn J. Drug prescribing for the elderly. Arch Intern Med 1986; 146: 2393-6
57. Katz IR. Drug treatment of depression in the frail elderly: discussion of the NIH consensus development conference on the diagnosis and treatment of depression in late life. Psychopharmacol Bull 1993; 29 (1): 101-8
58. Kerremans AL. Cytochrome P450 isoenzymes: importance for the internist. Neth J Med 1996; 48: 237-43
59. Nemeroff CB, DeVane CL, Pollock BG. Newer antidepressants and the cytochrome P450 system. Am J Psychiatry 1996 Mar; 153 (3): 311-20
60. Ereshefsky L, Riesenman C, Lam YW. Antidepressant drug interactions and the cytochrome P450 system: the role of cytochrome P450 2D6. Clin Pharmacokinet 1995; 29 Suppl. 1: 10-9
61. Brøsen K. Are pharmacokinetic drug interactions with the SSRIs an issue? Int Clin Psychopharmacol 1996; 11 Suppl. 1: 23-7
62. Ketter TA, Flockhart DA, Post RM, et al. The emerging role of cytochrome P450 3A in psychopharmacology. J Clin Psychopharmacol 1995; 15: 387-98
63. Knegtering H, Eijck M, Huijsman A. Effects of antidepressants on cognitive functioning of elderly patients: a review. Drugs Aging 1994 Sep; 5 (3): 192-9
64. Oxman TE. Antidepressants and cognitive impairment in the elderly. J Clin Psychiatry 1996; 57 Suppl. 5: 38-44
65. Leo R. Movement disorders associated with the serotonin-selective reuptake inhibitors. J Clin Psychiatry 1996; 57: 449-54
66. Richelson E. The pharmacology of antidepressants at the synapse: focus on newer compounds. J Clin Psychiatry 1994 Sep; 55 Suppl. A: 34-9
67. Cusack B, Nelson A, Richelson E. Binding of antidepressants to human brain receptors: focus on the newer generation compounds. Psychopharmacology 1994 May; 114 (4): 559-65
68. Laghrissithode F, Pollock BG, Miller MC, et al. Double-blind comparison of paroxetine and nortriptyline on the postural stability of late-life depressed patients. Psychopharmacol Bull 1995; 31 (4): 659-63
69. Preskorn SH. Recent pharmacologic advances in antidepressant treatment for the elderly. Am J Med 1993 May 24; 94 Suppl. 5A: 2-12S
70. Rosenbaum J. Managing selective serotonin reuptake inhibitor-drug interactions in clinical practice. Clin Pharmacokinet 1995; 29 Suppl. 1: 53-9
71. Amsterdam J, Brunswick D, Mendels J. The clinical application of tricyclic antidepressant pharmacokinetics and plasma levels. Am J Psychiatry 1980 Jun; 137 (6): 653-62
72. Feighner JP, Cohn JB. Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder. J Clin Psychiatry 1985 Mar; 46 (3): 20-5
73. Falk WE, Rosenbaum JF, Otto MW, et al. Fluoxeline versus trazodone in depressed geriatric patients. J Geriatr Psychiatry Neurol 1989; 2 (4): 208-14
74. Guillibert E, Pelcier Y, Archambault JC, et al. A double-blind multicenter study of paroxetine versus clomipramine in depressed elderly subjects. Acta Psychiatr Scand 1989; 80 Suppl. 350: 132-4
75. Cohn CK, Shirvastava R, Mendels J, et al. Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients. J Clin Psychiatry 1990 Dec; 51 Suppl. 12B: 28-33
76. Claghorn JL, Feighner JP. A double-blind comparison of paroxetine with imipramine in the long-term treatment of depression. J Clin Psychopharmacol 1993 Dec; 13 (6): 23S-7S
77. Geretsegger C, Stuppaeck CH, Mair M, et al. Multicenter double blind study of paroxetine and amitriptyline in elderly depressed inpatients. Psychopharmacology 1995; 119: 277-81
78. Miller FT, Freilicher J. Comparison of TCAs and SSRIs in the treatment of major depression in hospitalized geriatric patients. J Geriatr Psychiatry Neurol 1995 Jul; 8: 173-6
79. Glassman A, Ballenger J, Stokes P, et al. Tricyclic antidepressants: advantages and limitations. Geriatrics 1993 Nov; 48 Suppl. 2: 6-8
80. Roose SP, Glassman AH, Attia R, et al. Comparative efficacy of selective serotonin reuptake inhibitors in the treatment of melancholia. Am J Psychiatry 1994 Dec; 151 (12): 1735-9
81. Baldessarini RJ. Drugs and the treatment psychiatric disorders, depression and mania. In: Molinoff P, Ruddon R, editors. Goodman and Gilman's the pharmacologic basis of therapeutics. 9th ed. New York: McGraw Hill, 1996: 431-59
82. Drevets WC. Geriatric depression: brain imaging correlates and pharmacologic considerations. J Clin Psychiatry 1944 Sep; 55 Suppl. 9a: 71-81
83. Halikas JA. Org 3770 (mirtazapine) versus trazodone: a placebo-controlled trial in depressed elderly patients. Hum Psychopharmacol 1995; 10: S125-33
84. Frazer A. Pharmacology of antidepressants. J Clin Psychopharmacol 1997; 2 Suppl. 1: 2-18S
85. Gurian B, Rosowsky E. Low-dose methylphenidate in the very old. J Geriatr Psychiatry Neurol 1990 Jul-Sep; 3 (3): 152-4
86. Wallace AE, Kofoed LL, West AN. Double-blind, placebo-controlled trial of methylphenidate in older, depressed, medically ill patients. Am J Psychiatry 1995 Jun; 152 (6): 929-31
87. Georgotas A, McCue RE, Friedman E, et al. Response of depressive symptoms to nortriptyline, phenelzine and placebo. Br J Psychiatry 1987; 151: 102-6
88. Georgotas A, McCue RE, Cooper TB, et al. How effective and safe is continuation therapy in elderly depressed patients? Arch Gen Psychiatry 1988; 45: 929-33
89. Georgotas A, McCue RE, Cooper TB. A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients. Arch Gen Psychiatry 1989 Sep; 46: 783-6
90. Sunderland T, Cohen RM, Molchan S, et al. High-dose selegiline in treatment-resistant older depressive patients. Arch Gen Psychiatry 1994 Aug; 51 (8): 607-15
91. Nair NP, Ahmed SK, Ng Ying Kin NM, et al. Reversible and selective inhibitors of monoamine oxidase A in the treatment of depressed elderly patients. Acta Psychiatr Scand 1995; 91 Suppl. 386: 28-35
92. Reynolds III CF, Lebowitz BD, Schneider LS. The NIH consensus development conference on the diagnosis and treatment of depression in late life. Psychopharmacol Bull 1993; 29 (1): 83-95
93. Philibert RA, Richards L, Lynch CF, et al. Effect of ECT on mortality and clinical outcome in geriatric unipolar depression. J Clin Psychiatry 1995 Sep; 56 (9): 390-4
94. Thompson LW, Gallagher D, Steinmetz-Breckenridge J. Comparative effectiveness of psychotherapies for depressed elders. J Consult Clin Psychology 1987; 55: 385-90
95. Thompson LW. Cognitive-behavioral therapy and treatment for late-life depression. J Clin Psychiatry 1996; 57 Suppl. 5: 29-37
96. Steuer JL, Mintz J, Hammen CL, et al. Cognitive-behavioral and psychodynamic group psychotherapy in the treatment of geriatric depression. J Consult Clin Psychology 1984; 52: 80-9
97. Sadavoy J. Integrated psychotherapy for the elderly. Can J Psychiatry 1994; 39: S19-26
98. Scogin F, McElreath L. Efficacy of psychosocial treatments for geriatric depression: a quantitative review. J Consult Clin Psychology 1994; 62: 69-74
99. Reynolds III CF. Treatment of depression in late life. Am J Med 1994; 97; 39S-46S
100. Reynolds III CF, Frank E, Perel JM, et al. Combined pharmacotherapy and psychotherapy in the acute and continuation treatment of elderly patients with recurrent major depression: a preliminary report. Am J Psychiatry 1992; 149: 1687-92
101. Reynolds III CF, Frank E, Perel JM, et al. Maintenance therapies for late-life recurrent major depression: research and review circa 1995. Int Psychogeriatr 1995; 7: 27-39
102. Hinrichsen GA, Hernandez NA. Factors associated with recovery from and relapse into major depressive disorder in the elderly. Am J Psychiatry 1993 Dec; 150 (12): 1820-5
103. Kamath M, Finkel SI, Moran MB. A retrospective chart review of antidepressant use, effectiveness, and adverse effects in adults age 70 and older. Am J Geriatr Psychiatry 1996; 4: 167-72
104. Reynolds III CF, Frank E, Perel JM, et al. Treatment of consecutive episodes of major depression in the elderly. Am J Psychiatry 1994 Dec; 151 (12): 1740-3
105. Reynolds III CF. Recognition and differentiation of elderly depression in the clinical setting. Geriatrics 1995 Oct; 50 Suppl. 1: S6-15
106. Kushnir SL. Lithium-antidepressant combination in the treatment of depressed, physically ill geriatric patients. Am J Psychiatry 1986; 143: 378-9
107. Flint AJ, Rifat SL. A prospective study of lithium augmentation in antidepressant-resistant geriatric depression. J Clin Psychopharmacol 1994 Oct; 14 (5): 353-6
108. Weilburg JB, Rosenbaum JF, Biederman J, et al. Fluoxetine added to non-MAOI antidepressants converts nonresponders to responders: a preliminary report. J Clin Psychiatry 1989; 50: 447-9
109. Seth R, Jennings AL, Bindman J, et al. Combination treatment with noradrenaline and serotonin reuptake inhihitors in treatment resistant depression. Br J Psychiatry 1992; 161: 562-5
110. Reynolds III CF, Frank E, Perel JM, et al. High relapse rate after discontinuation of adjunctive medication for elderly patients with recurrent major depression. Am J Psychiatry 1996 Nov; 153 (11): 1418-22
111. Jorm AF. The epidemiology of depressive states in the elderly: implications for recognition, intervention and prevention. Soc Psychiatry Psychiatr Epidemiol 1995; 30: 53-9
112. Lebowitz B. Diagnosis and treatment of depression in late life. Am J Geriatr Psychiatry 1996; 4 Suppl. 1: S3-6
113. Pasternak RE, Reynolds III CF, Schlernitzauer M, et al. Acute open-trial of nortriptyline therapy of bereavement related depression in late life. J Clin Psychiatry 1991; 52: 307-10
114. Pasternak RE, Reynolds III CF, Frank E, et al. The temporal course of depressive symptoms and grief intensity in late-life spousal bereavement. Depression 1993; 1: 45-9
115. Jacobs SC, Nelson JC, Zisook S. Treating depressions of bereavement with antidepressants: a pilot study. Psychiatr Clin North Am 1987; 10: 501-10
116. Prigerson HG, Frank E, Kasl SV, et al. Complicated grief and bereavement-related depression as distinct disorders: preliminary empirical validation in elderly bereaved spouses. Am J Psychiatry 1995 Jan; 152 (1): 22-30
117. Prigerson HG, Bierhals AJ, Kasl SV, et al. Complicated grief as a disorder distinct from bereavement-related depression and anxiety: a replication study. Am J Psychiatry 1996 Nov; 153 (11): 1484-6
118. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994
119. Blazer DG, Bachar JR, Manton KG. Suicide in late life: review and commentary. J Am Geriatr Soc 1986; 34: 519-25
120. Kanowski S. Age-dependent epidemiology of depression. Gerontology 1994; 40 Suppl. 1: 1-4
121. Danto BL, Danto JM. Psychiatric treatment of the elderly suicidal patient. In: Lester D, Tallmer M, editors. Now I lay me down: suicide in the elderly. Philadelphia: Charles Press, 1994: 43-55
122. Conwell Y, Rotenberg M, Caine ED. Completed suicide at age 50 and over. J Am Geriatr Soc 1990; 38: 640-4
123. Lyness JM, Conwell Y, Nelson JC. Suicide attempts in elderly psychiatric inpatients. J Am Geriatr Soc 1992; 40: 320-4
124. Szanto K, Reynolds III CF, Frank E, et al. Suicide in elderly depressed patients: is active vs passive suicidal ideation a clinically valid distinction? Am J Geriatr Psychiatry 1996; 4: 197-207
125. Blazer D, Bachar JR, Hughes DC. Major depression with melancholia: a comparison of middle-aged and elderly adults. J Am Geriatr Soc 1987; 35: 927-32
126. Zweig RA, Hinrichsen GA. Factors associated with suicide attempts by depressed older adults: a prospective study. Am J Psychiatry 1993: 150: 1687-92
127. Jones JS, Stanley B, Mann JJ, et al. CSF 5-HIAA and HVA concentrations in elderly depressed patients who attempted suicide. Am J Psychiatry 1990; 147: 1225-7
128. Nordström P, Samuelsson M, Asberg M, et al. CSF 5-HIAA predicts suicide risk after attempted suicide. Suicide Life Threat Behav 1994; 24: 1-9
129. McIntosh JL, Santos JF, Hubbard RW, et al. Elder suicide: research, theory, and treatment. Washington, DC: American Psychological Association, 1994: 127-31
130. Meehan PJ, Saltzman LE, Sattin RW. Suicides among older United States residents: epidemiologic characteristics and trends. Am J Pub Health 1991; 81: 1198-200
131. Tallmer M. Symptoms and assessment of suicide in the elderly patient. In: Lester D, Tallmer M, editors. Now I lay me down: suicide in the elderly. Philadelphia: Charles Press, 1994: 17-30
132. Beck AT, Kovacs M, Weissman A. Assessment of suicidal intention: the scale for suicide ideation. J Consult Clin Psychology 1979; 47: 343-52
133. Beck AT, Steer RA, Kovacs M, et al. Hopelessness and eventual suicide: a 10-year prospective study of patients hospitalized with suicidal ideation. Am J Psychiatry 1985; 142: 559-63
134. Rifai AH, George CJ, Stack JA, et al. Hopelessness in suicide attempters after acute treatment of major depression in late life. Am J Psychiatry 1994; 151: 1687-90
135. Schifano F. Pharmacological strategies for preventing suicidal behaviour. CNS Drugs 1994; 1 (1): 16-25
136. Murray C, Lopez AD, editors. The global burden of disease. Cambridge (MA): Harvard University Press, 1996: 375-85